• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CGB
Click for more information
7.14% 0.8¢

CANN GLOBAL LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
CGB Supplementary Prospectus22/03/19
CGB Supplementary Prospectus22/02/19
CGB Supplementary Prospectus08/02/19
CGB STRATEGIC ALLIANCE WITH TGA & GMP APPROVED MANUFACTURERPRICE SENSITIVE08/02/19
CGB Quarterly Activities and Cashflow ReportPRICE SENSITIVE01/02/19
CGB Supplementary Prospectus25/01/19
CGB Change of name to Cann Global Limited25/01/19
CGB Clarification on earlier ASX waiver announcement17/01/19
CGB ASX APPROVAL LETTER AND TERMS OF ASX WAIVERS14/01/19
CGB Cover Letter and Supplementary Prospectus24/12/18
CGB Cover Note to Supplementary Prospectus and Relisting Update21/12/18
CGB Supplementary Prospectus14/12/18
CGB Supplementary Prospectus07/12/18
CGB Supplementary Prospectus28/11/18
CGB Results of Federal Court Hearing27/11/18
CGB Results of AGM27/11/18
CGB Appendix 3B and Cover Note26/11/18
CGB Fourth Supplementary Prospectus - Updated Timetable14/11/18
CGB Third Supplementary Prospectus - updated timetable07/11/18
CGB Quarterly Activities and Cashflow ReportPRICE SENSITIVE31/10/18
CGB Cover Note and Second Supplementary Prospectus31/10/18
CGB Notice of Annual General Meeting/Proxy Form29/10/18
CGB Strategic Collaboration Supply Agreement with Canadian LPPRICE SENSITIVE24/10/18
CGB Annual Report to shareholders23/10/18
CGB JV WITH LEADING ISRAELI CANNABIS COMPANY PHARMOCANNPRICE SENSITIVE19/10/18
CGB Cover Note and Supplementary ProspectusPRICE SENSITIVE18/10/18
CGB ODC MANUFACTURE LICENCE SECUREDPRICE SENSITIVE09/10/18
CGB Prospectus and Cover NotePRICE SENSITIVE01/10/18
CGB Recompliance ProspectusPRICE SENSITIVE28/09/18
CGB Results of Meeting14/09/18
CGB Chairperson's cover letter to the notice of meeting22/08/18
CGB QBL to Acquire International Health Food BrandsPRICE SENSITIVE16/08/18
CGB Notice of Extraordinary General Meeting/Proxy Form16/08/18
CGB Suspension Announcement - System UpgradePRICE SENSITIVE06/08/18
CGB Ground-breaking Discovery in Medicinal Cannabis Research01/08/18
CGB Suspension from Official QuotationPRICE SENSITIVE01/08/18
CGB Recompliance UpdatePRICE SENSITIVE01/08/18
CGB Quarterly Activities and Cashflow ReportPRICE SENSITIVE01/08/18
CGB Suspension from Official QuotationPRICE SENSITIVE01/08/18
CGB Trading HaltPRICE SENSITIVE30/07/18
CGB MEDICAL CANNABIS IMPORT & EXPORT LICENCES SECUREDPRICE SENSITIVE18/07/18 download Created with Sketch. 313.52KB
CGB Revised Timetable for Recompliance16/07/18 download Created with Sketch. 294.89KB
CGB Queensland Bauxite Shareholder Q and A13/07/18 download Created with Sketch. 317.98KB
CGB Open Letter From The Chairperson of QBL02/07/18 download Created with Sketch. 436.61KB
CGB Corporate Governance Statement29/06/18 download Created with Sketch. 506.82KB
CGB Q&A on the merger of QBL MCL and Medcan22/06/18 download Created with Sketch. 289.86KB
CGB Reinstatement to Official QuotationsPRICE SENSITIVE20/06/18 download Created with Sketch. 81.04KB
CGB COMPANY TRANSFORMATION ANNOUNCEMENTPRICE SENSITIVE20/06/18 download Created with Sketch. 8.23MB
CGB QBL to Recommence Trading on Thursday 21st June18/06/18 download Created with Sketch. 345.75KB
CGB Resumption of Trading of QBL08/06/18 download Created with Sketch. 101.53KB
CGB Update on Resumption of Trading01/06/18 download Created with Sketch. 100.51KB
CGB Voluntary Suspension Extension Request25/05/18 download Created with Sketch. 151.24KB
CGB Suspension Extension Request17/05/18
CGB Request For Voluntary Suspension extension 7 days09/05/18
CGB Suspension Extension Request07/05/18
CGB Suspension from Official QuotationPRICE SENSITIVE04/05/18
CGB Trading HaltPRICE SENSITIVE02/05/18
CGB Quarterly Activities and Cashflow ReportPRICE SENSITIVE01/05/18
CGB QBL BAUXITE TEAM IN CHINA26/04/18
CGB MCL secures access to Medical Cannabis import licensePRICE SENSITIVE20/04/18
CGB Coles Now Selling Hemp Products Provided by MCLPRICE SENSITIVE19/04/18
CGB MCL First to Release Australian Hemp Seed Oil CapsulesPRICE SENSITIVE18/04/18
CGB MCL Implementing Canntab Drug Development StrategyPRICE SENSITIVE29/03/18
CGB Cover Letter to Appendix 3B 19 03 201820/03/18
CGB Half Year Report and Accounts19/03/18
CGB Appendix 3B19/03/18
CGB A WORLD FIRST FOR MCL IN AUTOIMMUNE DISEASE RESEARCHPRICE SENSITIVE26/02/18
CGB Quarterly Activities and Cashflow ReportPRICE SENSITIVE01/02/18
CGB John Easterling -Amazon John- To Join Board of MCL18/01/18
CGB Reinstatement to official quotationPRICE SENSITIVE08/01/18
CGB MCL LEADS IN MEDICAL CANNABIS WITH CANADIAN DEALPRICE SENSITIVE08/01/18
CGB Request for Voluntary Suspension08/01/18
CGB Suspension from Official QuotationPRICE SENSITIVE08/01/18
CGB Request for Trading Halt04/01/18
CGB Trading HaltPRICE SENSITIVE04/01/18
CGB MCL Escalates Hemp Seed Food ProductionPRICE SENSITIVE27/12/17
CGB MCL and AEB join to develop Cannabis veterinary medications22/12/17
CGB MCL and AEB join to develop Cannabis veterinary medicationsPRICE SENSITIVE22/12/17
CGB Trading HaltPRICE SENSITIVE20/12/17
CGB Breakthrough for GMP Quality Medicinal CannabisPRICE SENSITIVE11/12/17
CGB South Johnstone Project UpdatePRICE SENSITIVE08/12/17
CGB Australias largest hemp food production underwayPRICE SENSITIVE07/12/17
CGB VitaHemp Product Launch Australian Grown GoodnessPRICE SENSITIVE27/11/17
CGB Momentous Deal with Premium Hemp Processing GroupPRICE SENSITIVE22/11/17
CGB Results of AGM15/11/17
CGB HISTORIC MOMENT FOR QBLPRICE SENSITIVE13/11/17
CGB Quarterly Activities and Cashflow ReportPRICE SENSITIVE31/10/17
CGB Anticipated Cashflow from MCL InvestmentPRICE SENSITIVE27/10/17
CGB Engagement of Israeli Medical Cannabis Research OrganisationPRICE SENSITIVE16/10/17
CGB MDL Granted on South Johnstone Bauxite ProjectPRICE SENSITIVE16/10/17
CGB Notice of Annual General Meeting/Proxy Form11/10/17
CGB Response to ASX price and volume queryPRICE SENSITIVE09/10/17
CGB Notice of Issue of Performance Shares04/10/17
CGB Annual Report to shareholders29/09/17
CGB Appendix 4G29/09/17
CGB Appendix 3B29/09/17
CGB Preparing Major Launch of MCL's Quality Vitahemp ProductsPRICE SENSITIVE26/09/17
CGB Unique Variations and High Levels of Cannabinoids IdentifiedPRICE SENSITIVE19/09/17
CGB MDL Work Programme ApprovedPRICE SENSITIVE13/09/17
CGB Results of General Meeting12/09/17
CGB Supplementary Prospectus
22/03/19
CGB Supplementary Prospectus
22/02/19
CGB Supplementary Prospectus
08/02/19
CGB STRATEGIC ALLIANCE WITH TGA & GMP APPROVED MANUFACTURER
08/02/19PRICE SENSITIVE
CGB Quarterly Activities and Cashflow Report
01/02/19PRICE SENSITIVE
CGB Supplementary Prospectus
25/01/19
CGB Change of name to Cann Global Limited
25/01/19
CGB Clarification on earlier ASX waiver announcement
17/01/19
CGB ASX APPROVAL LETTER AND TERMS OF ASX WAIVERS
14/01/19
CGB Cover Letter and Supplementary Prospectus
24/12/18
CGB Cover Note to Supplementary Prospectus and Relisting Update
21/12/18
CGB Supplementary Prospectus
14/12/18
CGB Supplementary Prospectus
07/12/18
CGB Supplementary Prospectus
28/11/18
CGB Results of Federal Court Hearing
27/11/18
CGB Results of AGM
27/11/18
CGB Appendix 3B and Cover Note
26/11/18
CGB Fourth Supplementary Prospectus - Updated Timetable
14/11/18
CGB Third Supplementary Prospectus - updated timetable
07/11/18
CGB Quarterly Activities and Cashflow Report
31/10/18PRICE SENSITIVE
CGB Cover Note and Second Supplementary Prospectus
31/10/18
CGB Notice of Annual General Meeting/Proxy Form
29/10/18
CGB Strategic Collaboration Supply Agreement with Canadian LP
24/10/18PRICE SENSITIVE
CGB Annual Report to shareholders
23/10/18
CGB JV WITH LEADING ISRAELI CANNABIS COMPANY PHARMOCANN
19/10/18PRICE SENSITIVE
CGB Cover Note and Supplementary Prospectus
18/10/18PRICE SENSITIVE
CGB ODC MANUFACTURE LICENCE SECURED
09/10/18PRICE SENSITIVE
CGB Prospectus and Cover Note
01/10/18PRICE SENSITIVE
CGB Recompliance Prospectus
28/09/18PRICE SENSITIVE
CGB Results of Meeting
14/09/18
CGB Chairperson's cover letter to the notice of meeting
22/08/18
CGB QBL to Acquire International Health Food Brands
16/08/18PRICE SENSITIVE
CGB Notice of Extraordinary General Meeting/Proxy Form
16/08/18
CGB Suspension Announcement - System Upgrade
06/08/18PRICE SENSITIVE
CGB Ground-breaking Discovery in Medicinal Cannabis Research
01/08/18
CGB Suspension from Official Quotation
01/08/18PRICE SENSITIVE
CGB Recompliance Update
01/08/18PRICE SENSITIVE
CGB Quarterly Activities and Cashflow Report
01/08/18PRICE SENSITIVE
CGB Suspension from Official Quotation
01/08/18PRICE SENSITIVE
CGB Trading Halt
30/07/18PRICE SENSITIVE
CGB MEDICAL CANNABIS IMPORT & EXPORT LICENCES SECURED
18/07/18PRICE SENSITIVE download Created with Sketch. 313.52KB
CGB Revised Timetable for Recompliance
16/07/18 download Created with Sketch. 294.89KB
CGB Queensland Bauxite Shareholder Q and A
13/07/18 download Created with Sketch. 317.98KB
CGB Open Letter From The Chairperson of QBL
02/07/18 download Created with Sketch. 436.61KB
CGB Corporate Governance Statement
29/06/18 download Created with Sketch. 506.82KB
CGB Q&A on the merger of QBL MCL and Medcan
22/06/18 download Created with Sketch. 289.86KB
CGB Reinstatement to Official Quotations
20/06/18PRICE SENSITIVE download Created with Sketch. 81.04KB
CGB COMPANY TRANSFORMATION ANNOUNCEMENT
20/06/18PRICE SENSITIVE download Created with Sketch. 8.23MB
CGB QBL to Recommence Trading on Thursday 21st June
18/06/18 download Created with Sketch. 345.75KB
CGB Resumption of Trading of QBL
08/06/18 download Created with Sketch. 101.53KB
CGB Update on Resumption of Trading
01/06/18 download Created with Sketch. 100.51KB
CGB Voluntary Suspension Extension Request
25/05/18 download Created with Sketch. 151.24KB
CGB Suspension Extension Request
17/05/18
CGB Request For Voluntary Suspension extension 7 days
09/05/18
CGB Suspension Extension Request
07/05/18
CGB Suspension from Official Quotation
04/05/18PRICE SENSITIVE
CGB Trading Halt
02/05/18PRICE SENSITIVE
CGB Quarterly Activities and Cashflow Report
01/05/18PRICE SENSITIVE
CGB QBL BAUXITE TEAM IN CHINA
26/04/18
CGB MCL secures access to Medical Cannabis import license
20/04/18PRICE SENSITIVE
CGB Coles Now Selling Hemp Products Provided by MCL
19/04/18PRICE SENSITIVE
CGB MCL First to Release Australian Hemp Seed Oil Capsules
18/04/18PRICE SENSITIVE
CGB MCL Implementing Canntab Drug Development Strategy
29/03/18PRICE SENSITIVE
CGB Cover Letter to Appendix 3B 19 03 2018
20/03/18
CGB Half Year Report and Accounts
19/03/18
CGB Appendix 3B
19/03/18
CGB A WORLD FIRST FOR MCL IN AUTOIMMUNE DISEASE RESEARCH
26/02/18PRICE SENSITIVE
CGB Quarterly Activities and Cashflow Report
01/02/18PRICE SENSITIVE
CGB John Easterling -Amazon John- To Join Board of MCL
18/01/18
CGB Reinstatement to official quotation
08/01/18PRICE SENSITIVE
CGB MCL LEADS IN MEDICAL CANNABIS WITH CANADIAN DEAL
08/01/18PRICE SENSITIVE
CGB Request for Voluntary Suspension
08/01/18
CGB Suspension from Official Quotation
08/01/18PRICE SENSITIVE
CGB Request for Trading Halt
04/01/18
CGB Trading Halt
04/01/18PRICE SENSITIVE
CGB MCL Escalates Hemp Seed Food Production
27/12/17PRICE SENSITIVE
CGB MCL and AEB join to develop Cannabis veterinary medications
22/12/17
CGB MCL and AEB join to develop Cannabis veterinary medications
22/12/17PRICE SENSITIVE
CGB Trading Halt
20/12/17PRICE SENSITIVE
CGB Breakthrough for GMP Quality Medicinal Cannabis
11/12/17PRICE SENSITIVE
CGB South Johnstone Project Update
08/12/17PRICE SENSITIVE
CGB Australias largest hemp food production underway
07/12/17PRICE SENSITIVE
CGB VitaHemp Product Launch Australian Grown Goodness
27/11/17PRICE SENSITIVE
CGB Momentous Deal with Premium Hemp Processing Group
22/11/17PRICE SENSITIVE
CGB Results of AGM
15/11/17
CGB HISTORIC MOMENT FOR QBL
13/11/17PRICE SENSITIVE
CGB Quarterly Activities and Cashflow Report
31/10/17PRICE SENSITIVE
CGB Anticipated Cashflow from MCL Investment
27/10/17PRICE SENSITIVE
CGB Engagement of Israeli Medical Cannabis Research Organisation
16/10/17PRICE SENSITIVE
CGB MDL Granted on South Johnstone Bauxite Project
16/10/17PRICE SENSITIVE
CGB Notice of Annual General Meeting/Proxy Form
11/10/17
CGB Response to ASX price and volume query
09/10/17PRICE SENSITIVE
CGB Notice of Issue of Performance Shares
04/10/17
CGB Annual Report to shareholders
29/09/17
CGB Appendix 4G
29/09/17
CGB Appendix 3B
29/09/17
CGB Preparing Major Launch of MCL's Quality Vitahemp Products
26/09/17PRICE SENSITIVE
CGB Unique Variations and High Levels of Cannabinoids Identified
19/09/17PRICE SENSITIVE
CGB MDL Work Programme Approved
13/09/17PRICE SENSITIVE
CGB Results of General Meeting
12/09/17
refresh Created with Sketch. REFRESH
 

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
Havilah hints at resource expansion from Mutooroo drilling in SA Havilah Resources Ltd is drilling for copper, cobalt and gold at its Mutooroo project in South Australia, hoping to expand its resource
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.